• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同时检测与 HCV 清除和治疗反应相关的 IL28B 基因座附近的 rs12979860 和 rs8099917 变异的基因型。

Simultaneous genotyping of rs12979860 and rs8099917 variants near the IL28B locus associated with HCV clearance and treatment response.

机构信息

Associated Regional and University Pathologists (ARUP) Institute for Clinical and Experimental Pathology, Salt Lake City, Utah 84108-1221, USA.

出版信息

J Mol Diagn. 2011 Jul;13(4):446-51. doi: 10.1016/j.jmoldx.2011.03.008. Epub 2011 May 14.

DOI:10.1016/j.jmoldx.2011.03.008
PMID:21704279
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3123790/
Abstract

Recent genome-wide association studies have identified two host single-nucleotide polymorphisms (SNPs) near the IL28B gene (rs12979860 C/T and rs8099917 T/G) that are associated with sustained virological response in patients infected with the hepatitis C virus. Herein, we describe a rapid multiplexed dual-color fluorescence resonance energy transfer (FRET) probe assay that accurately genotypes for both SNPs simultaneously. A single-nucleotide extension assay was also developed for verification of genotypes. Agreement (100%) was observed in genotype calls between the FRET and single-nucleotide extension methods for both SNPs, yielding 100% analytical sensitivity and specificity. By using the FRET assay, 443 samples of varying ethnic backgrounds were genotyped and six different compound genotypes (rs12979860/rs8099917) were detected in whites, Asians, Middle Easterners, Hispanics, and African Americans, at the following frequencies: CC/TT (39.2%, 78.9%, 40.0%, 33.9%, and 16.8%), CT/TT (20.8%, 0%, 40%, 9.3%, and 37.0%), TT/TT (2.4%, 0%, 0%, 3.4%, and 35.3%), CT/TG (24.0%, 19.7%, 20%, 39.8%, and 3.4%), TT/TG (8.0%, 1.4%, 0%, 3.4%, and 5.9%), and TT/GG (5.6%, 0%, 0%, 10.2%, and 1.7%), respectively. The multiplexed FRET assay can be used to effectively genotype for both SNPs in a single tube, with high analytical sensitivity and specificity.

摘要

最近的全基因组关联研究已经确定了两个位于 IL28B 基因附近的宿主单核苷酸多态性(SNP)(rs12979860C/T 和 rs8099917T/G),它们与丙型肝炎病毒感染患者的持续病毒学应答相关。在此,我们描述了一种快速的多重双色荧光共振能量转移(FRET)探针检测法,该方法可以同时准确地对这两个 SNP 进行基因分型。还开发了一种单核苷酸延伸检测法来验证基因型。FRET 和单核苷酸延伸方法在两种 SNP 的基因型判断中均具有 100%的一致性,从而产生了 100%的分析灵敏度和特异性。使用 FRET 检测法,对来自不同种族背景的 443 个样本进行了基因分型,在白人、亚洲人、中东人、西班牙裔和非裔美国人中发现了六种不同的复合基因型(rs12979860/rs8099917),其频率分别为:CC/TT(39.2%、78.9%、40.0%、33.9%和 16.8%)、CT/TT(20.8%、0%、40%、9.3%和 37.0%)、TT/TT(2.4%、0%、0%、3.4%和 35.3%)、CT/TG(24.0%、19.7%、20%、39.8%和 3.4%)、TT/TG(8.0%、1.4%、0%、3.4%和 5.9%)和 TT/GG(5.6%、0%、0%、10.2%和 1.7%)。该多重 FRET 检测法可用于在单个管中有效地对两个 SNP 进行基因分型,具有高分析灵敏度和特异性。

相似文献

1
Simultaneous genotyping of rs12979860 and rs8099917 variants near the IL28B locus associated with HCV clearance and treatment response.同时检测与 HCV 清除和治疗反应相关的 IL28B 基因座附近的 rs12979860 和 rs8099917 变异的基因型。
J Mol Diagn. 2011 Jul;13(4):446-51. doi: 10.1016/j.jmoldx.2011.03.008. Epub 2011 May 14.
2
IL28B gene polymorphism rs12979860, but not rs8099917, contributes to the occurrence of chronic HCV infection in Uruguayan patients.IL28B 基因多态性 rs12979860 而非 rs8099917 与乌拉圭患者慢性 HCV 感染的发生有关。
Virol J. 2018 Mar 2;15(1):40. doi: 10.1186/s12985-018-0946-2.
3
Strong prediction of virological response to combination therapy by IL28B gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4.IL28B基因变异rs12979860和rs8099917对慢性丙型肝炎4型患者联合治疗病毒学应答的强大预测作用
Liver Int. 2014 Jul;34(6):890-5. doi: 10.1111/liv.12321. Epub 2013 Oct 14.
4
Association of two polymorphisms of the IL28B gene with viral factors and treatment response in 1,518 patients infected with hepatitis C virus.在 1518 例丙型肝炎病毒感染患者中,IL28B 基因的两个多态性与病毒因素和治疗反应相关联。
J Gastroenterol. 2012 May;47(5):596-605. doi: 10.1007/s00535-012-0531-1. Epub 2012 Mar 23.
5
The predictive value of IL28B rs12979860, rs11881222 and rs8099917 polymorphisms and IP-10 in the therapeutic response of Egyptian genotype 4 patients.IL28B rs12979860、rs11881222 和 rs8099917 多态性及 IP-10 在埃及 4 型基因型患者治疗反应中的预测价值。
Virology. 2013 Sep;444(1-2):292-300. doi: 10.1016/j.virol.2013.06.025. Epub 2013 Jul 16.
6
Polymorphism of the IL28B gene (rs8099917, rs12979860) and virological response of Pakistani hepatitis C virus genotype 3 patients to pegylated interferon therapy.IL28B 基因(rs8099917、rs12979860)多态性与巴基斯坦丙型肝炎病毒基因型 3 患者对聚乙二醇干扰素治疗的病毒学应答。
Int J Infect Dis. 2015 Jan;30:91-7. doi: 10.1016/j.ijid.2014.09.021. Epub 2014 Nov 20.
7
Interleukin-28B (IL-28B) single-nucleotide polymorphisms and interferon plus ribavirin treatment outcome in Italian chronically HCV-infected patients.白细胞介素 28B(IL-28B)单核苷酸多态性与意大利慢性丙型肝炎病毒感染患者干扰素加利巴韦林治疗结局的关系。
J Viral Hepat. 2012 Sep;19(9):650-3. doi: 10.1111/j.1365-2893.2012.01606.x. Epub 2012 Apr 1.
8
A single IL28B genotype SNP rs12979860 determination predicts treatment response in patients with chronic hepatitis C Genotype 1 virus.单一 IL28B 基因型 SNP rs12979860 测定可预测慢性丙型肝炎基因型 1 病毒患者的治疗反应。
Eur J Gastroenterol Hepatol. 2011 Oct;23(10):931-5. doi: 10.1097/MEG.0b013e328349d0ef.
9
Association of interleukin-28B rs12979860 and rs8099917 polymorphisms with sustained viral response in hepatitis C virus genotype 1 and 3 infected patients from the Indian subcontinent.印度次大陆丙型肝炎病毒1型和3型感染患者中白细胞介素-28B基因rs12979860和rs8099917多态性与持续病毒学应答的关联
Indian J Med Microbiol. 2016 Jul-Sep;34(3):335-41. doi: 10.4103/0255-0857.188329.
10
Genetic polymorphism of IL28B in hepatitis C-infected haemophilia patients in Israel.以色列丙型肝炎感染血友病患者 IL28B 的遗传多态性。
Haemophilia. 2013 Jan;19(1):150-6. doi: 10.1111/j.1365-2516.2012.02932.x. Epub 2012 Aug 23.

引用本文的文献

1
Distribution of Single Nucleotide Polymorphism rs11322783 Genotypes in Patients with COVID-19.新型冠状病毒肺炎患者中单核苷酸多态性rs11322783基因型的分布情况
Microorganisms. 2022 Feb 4;10(2):363. doi: 10.3390/microorganisms10020363.
2
Role of serum level and genetic variation of IL-28B in interferon responsiveness and advanced liver disease in chronic hepatitis C patients.IL-28B血清水平及基因变异在慢性丙型肝炎患者干扰素反应性和晚期肝病中的作用
Med Microbiol Immunol. 2017 Apr;206(2):165-174. doi: 10.1007/s00430-017-0497-y. Epub 2017 Feb 18.
3
Recent advances in management of the HIV/HCV coinfected patient.HIV/HCV合并感染患者管理的最新进展。
Future Virol. 2015;10(8):981-997. doi: 10.2217/fvl.15.64.
4
Polymorphism Near the Interleukin-28B Gene and Anti-Hepatitis C Viral Response.白细胞介素-28B 基因附近的多态性与抗丙型肝炎病毒反应。
J Clin Transl Hepatol. 2013 Sep;1(1):39-44. doi: 10.14218/JCTH.2013.005XX. Epub 2013 Sep 15.
5
Demographics, clinical characteristics, IFNL3- and IFNL4- polymorphisms in a cohort of hepatitis C patients from Puerto Rico.来自波多黎各的一组丙型肝炎患者的人口统计学、临床特征、IFNL3和IFNL4基因多态性
P R Health Sci J. 2014 Dec;33(4):177-83.
6
Interferon lambda: opportunities, risks, and uncertainties in the fight against HCV.干扰素λ:抗丙型肝炎病毒斗争中的机遇、风险与不确定性
Front Immunol. 2014 Oct 31;5:545. doi: 10.3389/fimmu.2014.00545. eCollection 2014.
7
Reduction of microRNA 122 expression in IFNL3 CT/TT carriers and during progression of fibrosis in patients with chronic hepatitis C.IFNL3 CT/TT 携带者中 microRNA122 表达降低及慢性丙型肝炎患者纤维化进展过程中。
J Virol. 2014 Jun;88(11):6394-402. doi: 10.1128/JVI.00016-14. Epub 2014 Mar 26.
8
Randomized trial of peginterferon α-2a plus ribavirin versus peginterferon α-2b plus ribavirin for chronic hepatitis C in Japanese patients.聚乙二醇干扰素 α-2a 联合利巴韦林与聚乙二醇干扰素 α-2b 联合利巴韦林治疗日本慢性丙型肝炎患者的随机临床试验。
J Gastroenterol. 2012 Sep;47(9):1014-21. doi: 10.1007/s00535-012-0560-9. Epub 2012 Mar 2.

本文引用的文献

1
HCV substitutions and IL28B polymorphisms on outcome of peg-interferon plus ribavirin combination therapy.HCV 替换和 IL28B 多态性对聚乙二醇干扰素联合利巴韦林治疗的影响。
Gut. 2011 Feb;60(2):261-7. doi: 10.1136/gut.2010.223495. Epub 2010 Nov 10.
2
Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin.丙型肝炎病毒核心区的氨基酸替换和白细胞介素 28B 基因附近的遗传变异可预测替拉瑞韦与聚乙二醇干扰素和利巴韦林联合治疗的病毒应答。
Hepatology. 2010 Aug;52(2):421-9. doi: 10.1002/hep.23690.
3
Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus.白细胞介素 28B 多态性可改善病毒动力学,是基因型 1 丙型肝炎病毒持续病毒学应答的最强预处理预测因子。
Gastroenterology. 2010 Jul;139(1):120-9.e18. doi: 10.1053/j.gastro.2010.04.013. Epub 2010 Apr 24.
4
Interleukin-28b: a key piece of the hepatitis C virus recovery puzzle.白细胞介素-28b:丙型肝炎病毒恢复难题的关键一环。
Gastroenterology. 2010 Apr;138(4):1240-3. doi: 10.1053/j.gastro.2010.02.033. Epub 2010 Feb 23.
5
Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin.IL28B 基因变异与聚乙二醇干扰素和利巴韦林持续应答的复制关联。
Gastroenterology. 2010 Jun;138(7):2307-14. doi: 10.1053/j.gastro.2010.02.009. Epub 2010 Feb 19.
6
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study.IL28B 基因变异与慢性丙型肝炎及治疗失败相关:一项全基因组关联研究。
Gastroenterology. 2010 Apr;138(4):1338-45, 1345.e1-7. doi: 10.1053/j.gastro.2009.12.056. Epub 2010 Jan 11.
7
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus.白细胞介素28B的基因变异与丙型肝炎病毒的自发清除
Nature. 2009 Oct 8;461(7265):798-801. doi: 10.1038/nature08463.
8
IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy.IL28B与慢性丙型肝炎α干扰素和利巴韦林治疗的反应相关。
Nat Genet. 2009 Oct;41(10):1100-4. doi: 10.1038/ng.447. Epub 2009 Sep 13.
9
Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.IL28B全基因组与聚乙二醇化干扰素-α和利巴韦林治疗慢性丙型肝炎疗效的关联研究
Nat Genet. 2009 Oct;41(10):1105-9. doi: 10.1038/ng.449. Epub 2009 Sep 13.
10
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.白细胞介素28B的基因变异可预测丙型肝炎治疗诱导的病毒清除情况。
Nature. 2009 Sep 17;461(7262):399-401. doi: 10.1038/nature08309. Epub 2009 Aug 16.